Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sharon Bergeron"'
Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
Autor:
Sharon Bergeron, Van Huynh
Publikováno v:
Clinical Journal of Oncology Nursing. 21:E248-E259
Background Acute lymphoblastic leukemia (ALL) is a common cancer in children, and outcomes have greatly improved because of the refinement of multiagent chemotherapy regimens that include intensified asparaginase therapy. Asparaginase, a cornerstone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b68af0536d36ca896a09d0538dfba03
https://doi.org/10.1188/17.cjon.e248-e259
https://doi.org/10.1188/17.cjon.e248-e259
Autor:
Terzah M. Horton, Sharon Bergeron, Emasenyie Isikwei, Joel M. Reid, Charles G. Minard, Sarah Menig, Brenda J. Weigel, Elizabeth Fox, Xiaowei Liu, Katherine Tarlock, Todd M. Cooper
Publikováno v:
Journal of Clinical Oncology. 39:10018-10018
10018 Background: Outcomes for children with relapsed/refractory (R/R) AML and MDS are poor and new therapies are needed. Pevonedistat is an inhibitor of the NEDD-8 activating enzyme, a key regulator of the ubiquitin proteasome system that is respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f72d1bacd420fb6b6d791bdf9d7db41c
https://doi.org/10.1200/jco.2021.39.15_suppl.10018
https://doi.org/10.1200/jco.2021.39.15_suppl.10018
Autor:
Jennifer Saggio, Sharon Bergeron, Lindsay Quirk, Danelle Nielson, Tanea Washington, Joy Bartholomew
Publikováno v:
Journal of Pediatric Oncology Nursing. 34:5-12
Therapy combining dinutuximab with granulocyte macrophage colony stimulating factor, interleukin 2, and isotretinoin has significant side effects; however, these complications are generally predictable and can be managed proactively.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88547f805218d2705dc683ec1a6b619c
https://doi.org/10.1177/1043454216659448
https://doi.org/10.1177/1043454216659448
Autor:
Jennifer L. Pauley, Brigitte C. Widemann, Archie Bleyer, Maureen M. O'Brien, Stefan Schwartz, Frank M. Balis, Kjeld Schmiegelow, Anushree C. Shirali, Jesper Heldrup, Alexander A. Vinks, Sharon Bergeron, Laura B. Ramsey, David J. Askenazi
Publikováno v:
The Oncologist
An expert panel was convened to provide specific, expert consensus guidelines for the use of glucarpidase in patients who develop high‐dose methotrexate (HDMTX)‐induced nephrotoxicity and delayed methotrexate excretion. This guideline provides re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab970f1edf723e8e56c87c20c8b97e46
https://pubmed.ncbi.nlm.nih.gov/29079637
https://pubmed.ncbi.nlm.nih.gov/29079637
Autor:
Joy, Bartholomew, Tanea, Washington, Sharon, Bergeron, Danelle, Nielson, Jennifer, Saggio, Lindsay, Quirk
Publikováno v:
Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses. 34(1)
Therapy combining dinutuximab with granulocyte macrophage colony stimulating factor, interleukin 2, and isotretinoin has significant side effects; however, these complications are generally predictable and can be managed proactively.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::519b35c08e4e0a13435f3bb7e3ce9a12
https://pubmed.ncbi.nlm.nih.gov/27456981
https://pubmed.ncbi.nlm.nih.gov/27456981
Autor:
Richard Sposto, John H. Kersey, Marshall E. Kadin, Sharon Bergeron, Mark A. Lones, Nyla A. Heerema, Mitchell S. Cairo, Anna T. Meadows, Michelle M. Le Beau, Warren G. Sanger, Stuart E. Siegel, Sherrie L. Perkins, Jonathan D. Buckley, Carl R. Kjeldsberg, Minnie Abromowitch
Publikováno v:
Cancer Genetics and Cytogenetics. 172:1-11
Among pediatric non-Hodgkin lymphomas, one of the most frequent types is lymphoblastic lymphoma (LBL). Specific chromosome abnormalities are associated with prognosis in childhood acute lymphoblastic leukemia, but have not been evaluated for prognost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6478c8a9bc2d8a04018351a83ea209cf
https://doi.org/10.1016/j.cancergencyto.2006.07.011
https://doi.org/10.1016/j.cancergencyto.2006.07.011
Autor:
Mitchell S. Cairo, Carmella van de Ven, Sharon Bergeron, Joel Weinthal, Gregory H. Reaman, Leslie Garrison, Bruce R. Blazar, Mark Krailo, Rita Secola
Publikováno v:
Cancer. 83:1449-1460
BACKGROUND This Phase I trial was developed to determine the safety, biologic activity, and effects on hematopoietic recovery of PIXY321 following ifosfamide, carboplatin, and etoposide chemotherapy for children with recurrent or refractory solid tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99519280aa34c9c1720e3eccd483b15b
https://doi.org/10.1002/(sici)1097-0142(19981001)83:7<1449::aid-cncr24>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19981001)83:7<1449::aid-cncr24>3.0.co
Autor:
Sharon Bergeron
Publikováno v:
Journal of Pediatric Oncology Nursing. 15:98-102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a90a3d12ebce565459b2087f6eacf5
https://doi.org/10.1177/104345429801500208
https://doi.org/10.1177/104345429801500208
Autor:
Sherrie L. Perkins, J. Zhi, James R. Anderson, Lynette M. Smith, Mitchell S. Cairo, Howard J. Weinstein, Warren G. Sanger, Thomas G. Gross, Sharon Bergeron, Mark B. Geyer, Bruce Shiramizu, S. Goldman, Matthew J. Barth, Lauren Harrison
Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children’s Oncology Group report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34b03176923b8e40e438eb74024d7b86
https://europepmc.org/articles/PMC4539148/
https://europepmc.org/articles/PMC4539148/
Autor:
Sharon Bergeron, Bruce Shiramizu, Sherrie L. Perkins, Mitchell S. Cairo, [edited by] Michael A. Weiner, Kara M. Kelly, Mark A. Lones
Publikováno v:
Clinical lymphoma. 5(3)
Approximately 15% of all cases of childhood classical Hodgkin's disease (HD) express CD20, a B-cell marker associated with immunoglobulin heavy chain rearrangements. Immunoglobulin heavy chain rearrangements in Reed-Sternberg cells could be used to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f5711cdf0e2f1a32e53524c92876707
https://pubmed.ncbi.nlm.nih.gov/15636694
https://pubmed.ncbi.nlm.nih.gov/15636694